1887

Abstract

Sixty-four strains of intestinal bacteria were cultured under anaerobic conditions in lactulose-containing media to assess their ability to ferment lactulose. Some organisms were unable to metabolize the disaccharide, while others, e.g. clostridia and lactobacilli, metabolized lactulose extensively. Quantitative analyses of the fermentation products indicated that the major non-gaseous metabolites were acetic, lactic and butyric acids. Hydrogen and carbon dioxide were the only gases detected. Fermentation products were estimated for selected species throughout their growth cycles. The products of fermentation of lactulose by stool cultures varied with incubation conditions such as pH, but correlated well with those produced by pure cultures. These results are discussed in relation to the therapeutic uses of lactulose.

Loading

Article metrics loading...

/content/journal/micro/10.1099/00221287-128-2-319
1982-02-01
2021-05-18
Loading full text...

Full text loading...

/deliver/fulltext/micro/128/2/mic-128-2-319.html?itemId=/content/journal/micro/10.1099/00221287-128-2-319&mimeType=html&fmt=ahah

References

  1. Agostini L., Down P. F., Murison J., Wrong O. M. 1972; Faecal ammonia and pH during lactulose administration in man: comparison with other cathartics. Gut 13:859–866
    [Google Scholar]
  2. Bergeim O. 1940; Toxicity of intestinal volatile fatty acids for yeast and Escherichia coli. . Journal of Infectious Diseases 66:222–234
    [Google Scholar]
  3. Bircher J., Müller J., Guggenheim P., Haemmerli U. P. 1966; Treatment of chronic portal-systemic encephalopathy with lactulose. Lancet 1:890–893
    [Google Scholar]
  4. Bond J. H. Jr Levitt M. D. 1975; Investigation of small bowel transit time in man utilising pulmonary hydrogen (H2) measurements. Journal of Laboratory and Clinical Medicine 85:546–555
    [Google Scholar]
  5. Carulli J., Salvioli G. F., Manenti F. 1972; Absorption of lactulose in man. Digestion 6:139–145
    [Google Scholar]
  6. Conn H. O., Lieberthal M. M. 1979 The Hepatic Coma Syndromes and Lactulose. Baltimore: Williams & Wilkins.;
    [Google Scholar]
  7. Conn H. O., Leevy C. M., Vlahcevic Z. R., Rodgers J. B., Maddrey W. C., Seef L., Levy L. L. 1977; Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. Gastroenterology 72:573–583
    [Google Scholar]
  8. Dahlquist A., Gryboski I. 1965; Inability of the human small intestine to hydrolyse lactulose. Biochimica et biophysica acta 110:635–636
    [Google Scholar]
  9. Drasar B. S., Hill M. J. 1974 Human Intestinal Flora. London: Academic Press.;
    [Google Scholar]
  10. Elkington S. G. 1970; Lactulose. Gut 11:1043–1048
    [Google Scholar]
  11. Hoffmann K., Mossel D. A., Korus W., Van De Kamer J. H. 1964; Untersuchungen iiberdie Wirkungsweise der Lactulose im Darm. Klinische Wochenschrift 42:126–130
    [Google Scholar]
  12. Holdeman L. V., Cato E. P., Moore W. E. C. 1977 (editors) Anaerobe Laboratory Manual, 4th edn.. Blacksburg, Virginia, U.S.A.: V.P.I. Anaerobe Laboratory;
    [Google Scholar]
  13. Lee M., Gemmell E. 1971; Changes in the mouse intestinal microflora during weaning: role of volatile fatty acids. Infection and Immunity 5:1–7
    [Google Scholar]
  14. Menzies I. S., Mount J. N., Wheeler M. J. 1978; Quantitative estimation of clinically important monosaccharides in plasma by rapid thin-layer chromatography. Annals of Clinical Biochemistry 15:65–76
    [Google Scholar]
  15. Metz G., Jenkins D. J. A., Peters T. J., Newman A., Blendis L. M. 1975; Breath hydrogen as a diagnostic method for hypolactasia. Lancet 1:1155–1157
    [Google Scholar]
  16. Metz G., Jenkins D. J. A., Newman A., Blendis L. M. 1976; Breath hydrogen in hyposucrasia. Lancet 1:119–120
    [Google Scholar]
  17. Müller M., Walker-Smith J., Smerling D. H., Curtius H.-C., Prader A. 1969; Lactulose: a gas-liquid chromatography method of determination and evaluation of its use to assess intestinal mucosal damage. Clinica chimica acta 24:45–49
    [Google Scholar]
  18. Ruttloff H., Täufel A., Haenel H., Täufel K. 1967; Die intestinal-enzymatische Spaltung von Galakto-oligosacchariden im Darm von Tier und Mensch mit besonderer Berücksichtigung von Lactobacillus bifidus. 3: Mitt. Carbohydratische Aktivität ausgewählter Mikroorganismen der Darm- flora. Nährung 11:47–54
    [Google Scholar]
  19. Schutte H., Flossdorf J., Sahm H., Kula M.-R. 1976; Purification and properties of formaldehyde dehydrogenase and formate dehydrogenase from Candida boidinii. . European Journal of Biochemistry 62:151–160
    [Google Scholar]
  20. Simmons F., Goldstein H., Boyle J. D. 1970; A controlled clinical trial of lactulose in hepatic encephalopathy. Gastroenterology 59:827–832
    [Google Scholar]
  21. Udupihille M. 1974 Factors affecting human intestinal permeability of non-metabolized oligosaccharides. M.Phil. University of London:
    [Google Scholar]
  22. Vachek J. 1971; Spectrophotometric determination of lactulose. Československá farmacie 20:96–98
    [Google Scholar]
  23. Vince A., Zeegen R., Drinkwater J. E., O’Grady F., Dawson A. M. 1974; The effect of lactulose on the faecal flora of patients with hepatic encephalopathy. Journal of Medical Microbiology 7:163–168
    [Google Scholar]
  24. Vince A., Killingley M., Wrong O. M. 1978; Effect of lactulose on ammonia production in a faecal incubation system. Gastroenterology 74:544–549
    [Google Scholar]
  25. Wesselius-deCasparis A., Braadbaart S., Vdbergh-Bohlken G. E., Mimica M. 1968; Treatment of chronic constipation with lactulose syrup: results of a double-blind study. Gut 9:84–86
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/00221287-128-2-319
Loading
/content/journal/micro/10.1099/00221287-128-2-319
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error